Competitive inhibition of Ephrin-A1 and EphA2 binding by Perillaldehyde leads to decreased TRPM2 expression and reduced mitochondrial damage in vascular endothelial cells
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.114688 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Qian-Qian Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Xinxiang Medical University, Xinxiang, China, 453003. Electronic address: qianqianwang@xxmu.edu.cn. Hauptthemen laut MEDLINE: TRPM Cation Channels, Mitochondria, Endothelial Cells, Receptor, EphA2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province.
Abstract (Originalsprache)
BACKGROUND: Previous studies have demonstrated that perillaldehyde (PAE) exerts cardioprotective effects in animal models. Current evidence indicates that the intervening effect of PAE in cardiovascular diseases mainly involves the regulation of endothelial Ca2+ channels, the precise molecular mechanisms remain elusive. OBJECTIVE: This study aimed to elucidate the molecular mechanisms underlying PAE-mediated endothelial protection through the establishment of endothelium-specific TRPM2 transgenic and knockout murine models. STUDY DESIGN AND METHODS: We adopted a comprehensive experimental approach and utilized the established vascular injury model to evaluate the improvement of endothelial cells. The protocol included: (1) comprehensive assessment of endothelial function through vascular reactivity tests, (2) quantification of intracellular Ca2+ dynamics using fluorescent imaging, (3) molecular biology techniques to analyze TRPM2 pathway activity and EphA2 phosphorylation status. RESULTS: Our research results show that PAE can significantly improve endothelial dysfunction in rats with vascular injury Mechanistically, we explored two novel pathways: (1) PAE effectively suppressed TRPM2-mediated Ca2+ overload through channel inhibition (2) modulated EphA2 phosphorylation, thereby attenuating mitochondrial oxidative damage. These dual mechanisms synergistically improved endothelial cell viability. CONCLUSION: This study establishes PAE as a promising endothelial protectant with a unique dual-pathway mechanism involving coordinated inhibition of TRPM2-mediated calcium dysregulation and EphA2-dependent mitochondrial dysfunction. Our findings provide novel insights into phytochemical-based cardiovascular therapeutics and suggest potential clinical applications for PAE in endothelial pathology management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Xinxiang Medical University, Xinxiang, China, 453003. Electronic address: qianqianwang@xxmu.edu.cn.
- College of Pharmacy, Xinxiang Medical University, Xinxiang, China, 453003.
- College of Pharmacy, Xinxiang Medical University, Xinxiang, China, 453003. Electronic address: 041130@xxmu.edu.cn.
- College of Pharmacy, Xinxiang Medical University, Xinxiang, China, 453003. Electronic address: molizhu@xxmu.edu.cn.
Förderung
- Natural Science Foundation of Henan Province
Zitieren
APA
Wang, Q. Q., Li, C. Z., Que, H. D., Wang, H. D., Mao, B. Y., Li, P., Zhang, X., Zhan, H. Q., & Zhu, M. L. (2025). Competitive inhibition of Ephrin-A1 and EphA2 binding by Perillaldehyde leads to decreased TRPM2 expression and reduced mitochondrial damage in vascular endothelial cells. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114688
Vancouver
Wang QQ, Li CZ, Que HD, Wang HD, Mao BY, Li P, et al. Competitive inhibition of Ephrin-A1 and EphA2 binding by Perillaldehyde leads to decreased TRPM2 expression and reduced mitochondrial damage in vascular endothelial cells. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114688
BibTeX
@article{Wang2025,
author = {Wang, Qian-Qian and Li, Cheng-Zhi and Que, Hua-Dong and Wang, Hui-Dan and Mao, Bing-Yan and Li, Peng and Zhang, Xue and Zhan, He-Qin and Zhu, Mo-Li},
title = {Competitive inhibition of Ephrin-A1 and EphA2 binding by Perillaldehyde leads to decreased TRPM2 expression and reduced mitochondrial damage in vascular endothelial cells},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.114688}
}
EUVIMED